Institutional Ownership Elevation Oncology, Inc. (ELEV)
This table provides information about the institutional ownership of Elevation Oncology, Inc. (ELEV). We have compiled data on the 81 institutions that hold shares in the stock, with a total of 52 Million shares, which have been reported (via 13F filing form) to have a value of $30.1 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Logos Global Management LP
San Francisco, CA |
Aug 27, 2024 Q2 2024 |
3,850,000
shares
|
$2.27 Million
0.98% of portfolio
|
Q2 2024
Added 285.0%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
3,598,418
shares
|
$2.12 Million
0.05% of portfolio
|
Q2 2024
Reduced 7.42%
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2024 Q2 2024 |
3,060,000
shares
|
$1.81 Million
1.01% of portfolio
|
Q1 2024
Reduced 16.57%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 15, 2024 Q2 2024 |
2,958,579
shares
|
$1.75 Million
0.47% of portfolio
|
Q2 2024
New holding
|
|
Aisling Capital Management LP
New York, NY |
Aug 08, 2024 Q2 2024 |
2,834,910
shares
|
$1.67 Million
3.35% of portfolio
|
Q2 2021
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,490,249
shares
|
$1.47 Million
0.0% of portfolio
|
Q2 2024
Added 1348.65%
|
|
Balyasny Asset Management LLC
Chicago, IL |
Aug 14, 2024 Q2 2024 |
2,483,645
shares
|
$1.47 Million
0.01% of portfolio
|
Q2 2024
Reduced 18.72%
|
|
Braidwell LP
Stamford, CT |
Aug 14, 2024 Q2 2024 |
2,477,614
shares
|
$1.46 Million
0.21% of portfolio
|
Q2 2024
Added 4.2%
|
|
Ven Bio Partners LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
2,434,255
shares
|
$1.44 Million
3.71% of portfolio
|
Q2 2024
Reduced 9.71%
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
2,397,768
shares
|
$1.41 Million
0.03% of portfolio
|
Q2 2024
Added 58.7%
|
|
Bvf Inc
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
2,312,200
shares
|
$1.36 Million
0.19% of portfolio
|
Q2 2022
Added 0.0%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
1,917,043
shares
|
$1.13 Million
0.0% of portfolio
|
Q2 2024
Added 25.13%
|
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
Aug 14, 2024 Q2 2024 |
1,916,290
shares
|
$1.13 Million
0.63% of portfolio
|
Q2 2024
Reduced 17.86%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Aug 14, 2024 Q2 2024 |
1,800,106
shares
|
$1.06 Million
0.62% of portfolio
|
Q2 2024
Added 33.67%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Sep 16, 2024 Q2 2024 |
1,680,230
shares
|
$991,335
0.01% of portfolio
|
Q2 2024
Reduced 50.11%
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
1,468,825
shares
|
$866,606
0.54% of portfolio
|
Q2 2024
Added 15.76%
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
1,273,563
shares
|
$751,402
0.0% of portfolio
|
Q1 2024
Added 719.14%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
1,031,576
shares
|
$608,629
0.0% of portfolio
|
Q2 2024
Added 196.06%
|
|
Artal Group S.A.
Luxembourg, N4 |
Aug 14, 2024 Q2 2024 |
1,013,015
shares
|
$597,678
0.17% of portfolio
|
Q2 2024
Reduced 33.05%
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2024 Q2 2024 |
941,275
shares
|
$555,352
0.06% of portfolio
|
Q1 2024
Reduced 37.25%
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
897,033
shares
|
$529,249
0.0% of portfolio
|
Q2 2024
Added 711.06%
|
|
Octagon Capital Advisors LP
New York, NY |
Aug 14, 2024 Q2 2024 |
747,000
shares
|
$440,730
0.47% of portfolio
|
Q2 2024
New holding
|
|
Ikarian Capital, LLC
Dallas, TX |
Aug 14, 2024 Q2 2024 |
690,089
shares
|
$407,152
0.75% of portfolio
|
Q2 2024
Added 366.0%
|
|
Walleye Capital LLC
Plymouth, MN |
Aug 14, 2024 Q2 2024 |
615,837
shares
|
$363,343
0.0% of portfolio
|
Q2 2024
Reduced 21.71%
|
|
Ghost Tree Capital, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
600,000
shares
|
$354,000
0.66% of portfolio
|
Q2 2024
Added 140.0%
|